Serum neurotrophin concentrations in autism and mental retardation: A pilot study

Brain and Development

Volumn 26, Issue 5, 2004, Pages 292-295

  Miyazaki, Kaoru ^a   Narita, Naoko ^a,b   Sakuta, Ryoichi ^b   Miyahara, Tomoko ^a   Naruse, Hiroshi ^c   Okado, Nobuo ^a   Narita, Masaaki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b DOKKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Qual Contr Ctr for Mass screening   (Japan)

Author keywords

Autism; Brain derived neurotrophic factor; Mental retardation; Neurotrophin; Neurotrophin 4 5

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIN; NEUROTROPHIN 4;

ADOLESCENT; ANALYSIS OF VARIANCE; ARTICLE; AUTISM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MENTAL DEFICIENCY; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AUTISTIC DISORDER; BIOLOGICAL MARKERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT; MALE; MENTAL RETARDATION; NERVE GROWTH FACTORS; PILOT PROJECTS;

EID: 2542503520     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0387-7604(03)00168-2     Document Type: Article

References (13)

1. Charman T., Baird G. Practitioner review: diagnosis of autism spectrum disorder in 2- and 3-year-old children. J Child Psychol Psychiatry Allied Discip. 43:2002;289-305
2. Anderson G.M., Horne W.C., Chatterjee D., Cohen D.J. The hyperserotonemia of autism. Ann NY Acad Sci. 600:1990;331-340
3. Tani Y., Ishihara T. Simultaneous measurement of tetrahydrobiopterin (THBP) and biogenic amines by liquid chromatography with electrochemical detection. Life Sci. 46:1990;373-378
4. Dhossche D., Applegate H., Abraham A., Maertens P., Bland L., Bencsath A., et al. Elevated plasma gamma-aminobutyric acid (GABA) levels in autistic youngsters: stimulus for a GABA hypothesis of autism. Med Sci Monitor Int Med J Exp Clin Res. 8:2002;R1-R6
5. Betancur C., Corbex M., Spielewoy C., Philippe A., Laplanche J.L., Launay J.M., et al. Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder. Mol Psychiatry. 7:2002;67-71
6. Nelson K.B., Grether J.K., Croen L.A., Dambrosia J.M., Dickens B.F., Jelliffe L.L., et al. Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann Neurol. 49:2001;597-606
7. Tucker K.L., Meyer M., Barde Y.A. Neurotrophins are required for nerve growth during development. Nat Neurosci. 4:2001;29-37
8. Xiong H., Futamura T., Jourdi H., Zhou H., Takei N., Diverse-Pierluissi M., et al. Neurotrophins induce BDNF expression through the glutamate receptor pathway in neocortical neurons. Neuropharmacology. 42:2002;903-912
9. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV. 1994;American Psychiatric Association, Washington, DC
10. Karege F., Schwald M., Cisse M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett. 328:2002;261-264
11. Mamounas L.A., Ble M.E., Suiciak J.A., Altar C.A. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J Neurosci. 15:1995;7929-7939
12. Siuciak J.A., Boylan C., Fritsche M., Altar C.A., Lindsay R.M. BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration. Brain Res. 710:1996;11-20
13. Narita N., Kato M., Tazoe M., Miyazaki K., Narita M., Okado N. Increased monoamine concentration in the brain and the blood of fetal thalidomide and valproic acid exposed rat; putative animal models for autism. Pediatr Res. 52:2002;576-579